TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer
Herbst, Roy S, Prager, Diane, Hermann, Robert, Fehrenbacher, Lou, Johnson, Bruce E, Sandler, Alan, Kris, Mark G, Tran, Hai T, Klein, Pam, Li, Xin, Ramies, David, Johnson, David H, Miller, Vincent A
Published in Journal of clinical oncology (01.09.2005)
Published in Journal of clinical oncology (01.09.2005)
Get full text
Journal Article
Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib
EBERHARD, David A, JOHNSON, Bruce E, KLEIN, Pam, MILLER, Vincent A, OSTLAND, Michael A, RAMIES, David A, SEBISANOVIC, Dragan, STINSON, Jeremy A, ZHANG, Yu R, SESHAGIRI, Somasekar, HILLAN, Kenneth J, AMLER, Lukas C, GODDARD, Audrey D, HELDENS, Sherry L, HERBST, Roy S, INCE, William L, JÄNNE, Pasi A, JANUARIO, Thomas, JOHNSON, David H
Published in Journal of clinical oncology (01.09.2005)
Published in Journal of clinical oncology (01.09.2005)
Get full text
Journal Article
Investigation of the Prognostic and Predictive Value of Thymidylate Synthase, p53, and Ki-67 in Patients With Locally Advanced Colon Cancer
ALLEGRA, Carmen J, PARR, Allyson L, KUGLER, John W, TIRONA, Maria Tria, GOLDBERG, Richard M, WOLD, Lester E, MAHONEY, Michelle R, SARGENT, Daniel J, JOHNSTON, Patrick, KLEIN, Pam, BEHAN, Katie, O'CONNELL, Michael J, LEVITT, Ralph
Published in Journal of clinical oncology (01.04.2002)
Published in Journal of clinical oncology (01.04.2002)
Get full text
Journal Article
Abstract P037: A phase 1/2 dose escalation and expansion study of OP-1250 in adults with advanced and/or metastatic hormone receptor-positive (HR+), HER2-negative (HER2−) breast cancer
Alemany, Carlos, Patel, Manish, Mitri, Zahi, Sparano, Joseph, Borges, Virginia, Makower, Della, Klein, Pam, Lawrence, Julia, Le, Trinh, Zujewski, Jo Anne, Harmilton, Erika
Published in Molecular cancer therapeutics (01.12.2021)
Published in Molecular cancer therapeutics (01.12.2021)
Get full text
Journal Article
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
Kearney, Matthew, Franks, Lauren, Lee, Shing, Tiersten, Amy, Makower, Della F., Cigler, Tessa, Mundi, Prabhjot, Chi, Dow-Chung, Goel, Anupama, Klein, Pam, Andreopoulou, Eleni, Sparano, Joseph, Trivedi, Meghna, Accordino, Melissa, Califano, Andrea, Hershman, Dawn L., Silva, Jose, Kalinsky, Kevin
Published in Breast cancer research and treatment (01.08.2021)
Published in Breast cancer research and treatment (01.08.2021)
Get full text
Journal Article
Abstract 5588: A phase I, open label, dose escalation study of an oral mammalian target of rapamycin inhibitor INK128 administered once daily in patients with advanced malignancies
Infante, Jeffrey R., Tabernero, Josep, Burris, Howard A., Macarulla, Teresa, Martin, Michael, Liu, Yi, Jessen, Katti, Koczon, Ethel, Rommel, Christian, Klein, Pam M., Berk, Greg I., Bui, Lynne A., Gordon, Michael S.
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling
Jenkins, Jean, Calzone, Kathleen A, Dimond, Eileen, Liewehr, David J, Steinberg, Seth M, Jourkiv, Oxana, Klein, Pam, Soballe, Peter W, Prindiville, Sheila A, Kirsch, Ilan R
Published in Genetics in medicine (01.08.2007)
Published in Genetics in medicine (01.08.2007)
Get full text
Journal Article
Allosteric modulation of the adenosine A(1) receptor. Synthesis and biological evaluation of novel 2-amino-3-benzoylthiophenes as allosteric enhancers of agonist binding
van der Klein, PAM, Kourounakis, AP, IJzerman, AP
Published in Journal of medicinal chemistry (09.09.1999)
Published in Journal of medicinal chemistry (09.09.1999)
Get full text
Journal Article
5 '-O-alkyl ethers of N,2-substituted adenosine derivatives: Partial agonists for the adenosine A(1) and A(3) receptors
van Tilburg, EW, van der Klein, PAM, von Frijtag, J, Kunzel, D, de Groote, M, Stannek, C, Lorenzen, A, IJzerman, AP
Published in Journal of medicinal chemistry (30.08.2001)
Published in Journal of medicinal chemistry (30.08.2001)
Get full text
Journal Article
TRIBUTA: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer
HERBST, Roy S, PRAGER, Diane, RAMIES, David, JOHNSON, David H, MILLER, Vincent A, HERMANN, Robert, FEHRENBACHER, Lou, JOHNSON, Bruce E, SANDLER, Alan, KRIS, Mark G, TRAN, Hai T, KLEIN, Pam, XIN LI
Published in Journal of clinical oncology (2005)
Get full text
Published in Journal of clinical oncology (2005)
Journal Article